Neuberger Berman Group
ANAC

Neuberger Berman Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Neuberger Berman Group’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-9,300
Closed -$497K – 1641
2016
Q1 		$497K Sell
9,300
-15,037
-62% -$1.11M ﹤0.01% 1264
2015
Q4 		$2.75M Sell
24,337
-8,852
-27% -$975K ﹤0.01% 962
2015
Q3 		$3.91M Buy
+33,189
New +$4.33M 0.01% 923

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Neuberger Berman Group's ANAC Position: Q2 2016 in Review

Neuberger Berman Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 9,300 shares — an estimated $497K sold.

Neuberger Berman Group first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $3.91M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Neuberger Berman Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Neuberger Berman Group sold 9,300 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $497K.
  • Neuberger Berman Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
  • Neuberger Berman Group's ANACOR PHARMACEUTICALS INC COM position peaked at $3.91M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Neuberger Berman Group's 13F filing for Q2 2016, filed 5 Aug 2016.